BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 12773076)

  • 1. Tenofovir disoproxil fumarate.
    Grim SA; Romanelli F
    Ann Pharmacother; 2003 Jun; 37(6):849-59. PubMed ID: 12773076
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tenofovir disoproxil fumarate: a nucleotide reverse transcriptase inhibitor for the treatment of HIV infection.
    Fung HB; Stone EA; Piacenti FJ
    Clin Ther; 2002 Oct; 24(10):1515-48. PubMed ID: 12462284
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emtricitabine/tenofovir disoproxil fumarate.
    Drugs R D; 2004; 5(3):160-1. PubMed ID: 15139777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tenofovir disoproxil fumarate.
    Gallant JE; Deresinski S
    Clin Infect Dis; 2003 Oct; 37(7):944-50. PubMed ID: 13130407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tenofovir disoproxil fumarate: clinical pharmacology and pharmacokinetics.
    Kearney BP; Flaherty JF; Shah J
    Clin Pharmacokinet; 2004; 43(9):595-612. PubMed ID: 15217303
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tenofovir disoproxil fumarate (Viread) for the treatment of HIV infection.
    Gallant JE; Pham PA
    Expert Rev Anti Infect Ther; 2003 Oct; 1(3):415-22. PubMed ID: 15482138
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tenofovir disoproxil fumarate.
    Chapman T; McGavin J; Noble S
    Drugs; 2003; 63(15):1597-608. PubMed ID: 12887265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tenofovir disoproxil fumarate: a review of its use in the management of HIV infection.
    Lyseng-Williamson KA; Reynolds NA; Plosker GL
    Drugs; 2005; 65(3):413-32. PubMed ID: 15669881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tenofovir disoproxil fumarate for the treatment of HIV infection.
    Pham PA; Gallant JE
    Expert Opin Drug Metab Toxicol; 2006 Jun; 2(3):459-69. PubMed ID: 16863446
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of tenofovir DF vs stavudine in combination therapy in antiretroviral-naive patients: a 3-year randomized trial.
    Gallant JE; Staszewski S; Pozniak AL; DeJesus E; Suleiman JM; Miller MD; Coakley DF; Lu B; Toole JJ; Cheng AK;
    JAMA; 2004 Jul; 292(2):191-201. PubMed ID: 15249568
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tenofovir disoproxil fumarate (Viread).
    Porche DJ
    J Assoc Nurses AIDS Care; 2002; 13(3):100-2. PubMed ID: 12064015
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of hexadecyloxypropyl-9-R-[2-(Phosphonomethoxy)propyl]- adenine, CMX157, as a potential treatment for human immunodeficiency virus type 1 and hepatitis B virus infections.
    Painter GR; Almond MR; Trost LC; Lampert BM; Neyts J; De Clercq E; Korba BE; Aldern KA; Beadle JR; Hostetler KY
    Antimicrob Agents Chemother; 2007 Oct; 51(10):3505-9. PubMed ID: 17646420
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tenofovir: a nucleotide analog for the management of human immunodeficiency virus infection.
    Antoniou T; Park-Wyllie LY; Tseng AL
    Pharmacotherapy; 2003 Jan; 23(1):29-43. PubMed ID: 12523458
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tenofovir disoproxil fumarate-emtricitabine coformulation for once-daily dual NRTI backbone.
    Muñoz de Benito RM; Arribas López JR
    Expert Rev Anti Infect Ther; 2006 Aug; 4(4):523-35. PubMed ID: 17009933
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tenofovir disoproxil fumarate and an optimized background regimen of antiretroviral agents as salvage therapy: impact on bone mineral density in HIV-infected children.
    Gafni RI; Hazra R; Reynolds JC; Maldarelli F; Tullio AN; DeCarlo E; Worrell CJ; Flaherty JF; Yale K; Kearney BP; Zeichner SL
    Pediatrics; 2006 Sep; 118(3):e711-8. PubMed ID: 16923923
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tenofovir disoproxil fumarate.
    Kumar A
    Drugs; 2003; 63(15):1609-10. PubMed ID: 12887267
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of tenofovir on didanosine absorption in patients with HIV.
    Pecora Fulco P; Kirian MA
    Ann Pharmacother; 2003 Sep; 37(9):1325-8. PubMed ID: 12921517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early virologic nonresponse to tenofovir, abacavir, and lamivudine in HIV-infected antiretroviral-naive subjects.
    Gallant JE; Rodriguez AE; Weinberg WG; Young B; Berger DS; Lim ML; Liao Q; Ross L; Johnson J; Shaefer MS;
    J Infect Dis; 2005 Dec; 192(11):1921-30. PubMed ID: 16267763
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of tenofovir disoproxil fumarate for the treatment of nucleoside-resistant HIV-1.
    McColl DJ; Miller MD
    J Antimicrob Chemother; 2003 Feb; 51(2):219-23. PubMed ID: 12562684
    [No Abstract]   [Full Text] [Related]  

  • 20. Tenofovir disoproxil fumarate.
    Antoniou T
    Drugs; 2003; 63(15):1609-10. PubMed ID: 12887266
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.